P. Roux, V. Villes, J. Blanche, D. Bry, B. Spire et al., Buprenorphine in primary care: Risk factors for treatment injection and implications for clinical management, Drug and Alcohol Dependence, vol.97, issue.1-2, pp.1-2105, 2008.
DOI : 10.1016/j.drugalcdep.2008.03.025

M. Auriacombe, M. Fatseas, J. Dubernet, J. Daulouede, and J. Tignol, French Field Experience with Buprenorphine, American Journal on Addictions, vol.13, issue.s1, pp.17-28, 2004.
DOI : 10.1080/10550490490440780

M. Carrieri, L. Amass, G. Lucas, D. Vlahov, A. Wodak et al., Buprenorphine Use: The International Experience, Clinical Infectious Diseases, vol.43, issue.Supplement 4, pp.197-215, 2006.
DOI : 10.1086/508184

URL : https://academic.oup.com/cid/article-pdf/43/Supplement_4/S197/789536/43-Supplement_4-S197.pdf

P. Carrieri, L. Michel, C. Lions, J. Cohen, M. Vray et al., Methadone Induction in Primary Care for Opioid Dependence: A Pragmatic Randomized Trial (ANRS Methaville), PLoS ONE, vol.376, issue.11, p.4231094, 2014.
DOI : 10.1371/journal.pone.0112328.s002

R. Mattick, C. Breen, J. Kimber, and M. Davoli, Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence, Cochrane Database Syst Rev, vol.2, p.24500948, 2014.
DOI : 10.1002/14651858.cd002207.pub2

J. Delorme, C. Chenaf, J. Kabore, B. Pereira, A. Mulliez et al., Incidence of high dosage buprenorphine and methadone shopping behavior in a retrospective cohort of opioid-maintained patients in France, Drug and Alcohol Dependence, vol.162, pp.99-106, 2016.
DOI : 10.1016/j.drugalcdep.2016.02.035

S. Lake, K. Hayashi, J. Buxton, M. Milloy, H. Dong et al., The effect of prescription opioid injection on the risk of non-fatal overdose among people who inject drugs, Drug and Alcohol Dependence, vol.156, pp.297-303, 2015.
DOI : 10.1016/j.drugalcdep.2015.09.026

H. Peyriere, C. Eiden, J. Micallef, M. Lapeyre-mestre, J. Faillie et al., Slow-Release Oral Morphine Sulfate Abuse: Results of the Postmarketing Surveillance Systems for Psychoactive Prescription Drug Abuse in France, European Addiction Research, vol.19, issue.5, pp.235-279, 2013.
DOI : 10.1159/000346179

M. Yokell, N. Zaller, T. Green, and J. Rich, Buprenorphine and Buprenorphine/Naloxone Diversion, Misuse, and Illicit Use: An International Review, Current Drug Abuse Reviewse, vol.4, issue.1, pp.28-41, 2011.
DOI : 10.2174/1874473711104010028

R. Dwyer, L. Topp, L. Maher, R. Power, M. Hellard et al., Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug users, Drug and Alcohol Dependence, vol.100, issue.1-2, pp.9-16, 2009.
DOI : 10.1016/j.drugalcdep.2008.08.016

D. Giudice and P. , Cutaneous complications of intravenous drug abuse, British Journal of Dermatology, vol.82, issue.1, pp.1-10, 2004.
DOI : 10.1056/NEJM199506293322606

C. Diot, C. Eiden, H. Lenoir, M. Chammas, S. Xatart et al., Fasciites n??crosantes li??es ?? des injections de morphine (Sk??nan??) chez un patient infect?? par le VIH, Th??rapie, vol.69, issue.2, pp.182-187, 2014.
DOI : 10.2515/therapie/2013073

D. Shlomi, D. Shitrit, D. Bendayan, G. Sahar, Y. Shechtman et al., Successful lung transplantation for talcosis secondary to intravenous abuse of oral drug, Int J Chron Obstruct Pulmon Dis, vol.3, issue.2, pp.327-357, 2008.

D. Lamb and G. Roberts, Starch and talc emboli in drug addicts' lungs, Journal of Clinical Pathology, vol.25, issue.10, pp.876-81, 1972.
DOI : 10.1136/jcp.25.10.876

URL : http://jcp.bmj.com/content/jclinpath/25/10/876.full.pdf

B. Waller, W. Brownlee, and W. Roberts, Self-Induced Pulmonary Granulomatosis, Chest, vol.78, issue.1, pp.90-94, 1980.
DOI : 10.1378/chest.78.1.90

P. Roux, L. Gall, J. Debrus, M. Protopopescu, C. Ndiaye et al., Innovative community-based educational face-to-face intervention to reduce HIV, hepatitis C virus and other blood-borne infectious risks in difficult-to-reach people who inject drugs: results from the ANRS-AERLI intervention study, Addiction, vol.21, issue.40, pp.94-106, 2016.
DOI : 10.1080/09540120802657522

C. Haasen, U. Verthein, P. Degkwitz, J. Berger, M. Krausz et al., Heroin-assisted treatment for opioid dependence: Randomised controlled trial, The British Journal of Psychiatry, vol.191, issue.1, pp.55-62, 2007.
DOI : 10.1192/bjp.bp.106.026112

URL : http://bjp.rcpsych.org/content/bjprcpsych/191/1/55.full.pdf

J. Strang, N. Metrebian, N. Lintzeris, L. Potts, T. Carnwath et al., Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial, The Lancet, vol.375, issue.9729, pp.1885-95, 2010.
DOI : 10.1016/S0140-6736(10)60349-2

E. Oviedo-joekes, S. Brissette, D. Marsh, P. Lauzon, D. Guh et al., Diacetylmorphine versus Methadone for the Treatment of Opioid Addiction, New England Journal of Medicine, vol.361, issue.8, pp.777-86, 2009.
DOI : 10.1056/NEJMoa0810635

I. Demaret, E. Quertemont, G. Litran, C. Magoga, C. Deblire et al., Efficacy of Heroin-Assisted Treatment in Belgium: A Randomised Controlled Trial, European Addiction Research, vol.21, issue.4, pp.179-87, 2015.
DOI : 10.1159/000369337

J. Strang, T. Groshkova, A. Uchtenhagen, W. Van-den-brink, C. Haasen et al., Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction, The British Journal of Psychiatry, vol.207, issue.1, pp.5-14, 2015.
DOI : 10.1192/bjp.bp.114.149195

S. Boyd, M. D. Snap, and D. Macpherson, Telling our stories: heroin-assisted treatment and SNAP activism in the Downtown Eastside of Vancouver, Harm Reduction Journal, vol.379, issue.16, pp.27-12954, 2017.
DOI : 10.1016/S0140-6736(11)61423-2

M. Kahan, A. Srivastava, A. Ordean, and S. Cirone, Buprenorphine: new treatment of opioid addiction in primary care, Epub 16, pp.281-290, 2011.

M. Lofwall and S. Walsh, A Review of Buprenorphine Diversion and Misuse, Journal of Addiction Medicine, vol.8, issue.5, pp.315-341, 2014.
DOI : 10.1097/ADM.0000000000000045

H. Peyriere, E. Nogue, C. Eiden, E. Frauger, M. Charra et al., Evidence of slow-release morphine sulfate abuse and diversion: epidemiological approaches in a French administrative area, Fundamental & Clinical Pharmacology, vol.29, issue.Suppl 1, pp.466-75, 2016.
DOI : 10.1111/j.1472-8206.2011.00950.x

E. Lloyd-smith, E. Wood, R. Zhang, M. Tyndall, S. Sheps et al., Determinants of hospitalization for a cutaneous injection-related infection among injection drug users: a cohort study, BMC Public Health, vol.69, issue.1, pp.327-20534148, 2010.
DOI : 10.15288/jsad.2008.69.924

E. Wood, M. Tyndall, Z. Qui, R. Zhang, J. Montaner et al., Service Uptake and Characteristics of Injection Drug Users Utilizing North America???s First Medically Supervised Safer Injecting Facility, American Journal of Public Health, vol.96, issue.5, pp.770-773, 2006.
DOI : 10.2105/AJPH.2004.057828

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1470579/pdf

C. Potier, V. Laprevote, F. Dubois-arber, O. Cottencin, and R. B. , Supervised injection services: What has been demonstrated? A systematic literature review, Drug and Alcohol Dependence, vol.145, pp.48-68, 2014.
DOI : 10.1016/j.drugalcdep.2014.10.012

M. Islam, L. Topp, K. Conigrave, I. Van-beek, L. Maher et al., The reliability of sensitive information provided by injecting drug users in a clinical setting: Clinician-administered versus audio computer-assisted self-interviewing (ACASI), AIDS Care, vol.30, issue.1, 2012.
DOI : 10.1080/09540120701192837

S. Darke, Self-report among injecting drug users: A review, Drug and Alcohol Dependence, vol.51, issue.3, pp.253-63, 1998.
DOI : 10.1016/S0376-8716(98)00028-3

S. Comer, M. Sullivan, R. Whittington, S. Vosburg, and W. Kowalczyk, Abuse Liability of Prescription Opioids Compared to Heroin in Morphine-Maintained Heroin Abusers, Neuropsychopharmacology, vol.272, issue.5, pp.1179-91, 2008.
DOI : 10.1016/0376-8716(96)01274-4

G. Decocq, D. Fremaux, A. Smail, M. Compagnon, and M. Andrejak, Local complications after intravenous injection of dissolved tablets of buprenorphine, Presse Med, vol.26, issue.30, pp.1433-9404358, 1997.

N. Volkow, T. Frieden, P. Hyde, and S. Cha, Medication-Assisted Therapies ??? Tackling the Opioid-Overdose Epidemic, New England Journal of Medicine, vol.370, issue.22, pp.2063-2069, 2014.
DOI : 10.1056/NEJMp1402780

P. Blanken, V. Hendriks, J. Van-ree, and W. Van-den-brink, Outcome of long-term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in the Netherlands, Addiction, vol.175, issue.2, pp.300-308, 2010.
DOI : 10.1136/bmj.317.7150.13